DALLAS, Dec. 13 /PRNewswire-FirstCall/ -- Keith Houser, Chairman and CEO of BioTech Medics, Inc., (Pink Sheets: BTMD) stated today: "One key goal for BioTech Medics is to become a reporting public company and to register with the SEC with audited financial statements from a reputable CPA firm as soon as practicable. BTMD intends, in full compliance with the Securities Act of 1934, as Amended, to ultimately move up to a major national stock exchange, or listing on a recognized trading system as soon as possible. Therefore, BTMD is pleased to announce today the engagement of the CPA firm Bagell, Josephs & Co."
"I have personally met with two partners of the CPA firm Bagell, Josephs & Co. Mr. Neil Levine, CPA and Mr. Michael Pollack, CPA. I found them knowledgeable and the firm capable of handling BTMD's financial and SEC needs," said Mr. Houser.
Neil Levine has spent over twenty years in public accounting. His experience includes consulting for both privately held and public companies. Neil currently manages the firm's SEC Audit and Review Practice. He has oversees quality control and compliance with the regulations of the PCAOB.
Mr. Levine is a member of the American Institute of Certified Public Accountants, The Pennsylvania Institute of CPAs, and is licensed in the states of New Jersey, Pennsylvania, Florida, and Connecticut.
Michael Pollack has over sixteen years in the realm of public accounting as well as consulting to various publicly traded and private companies. He has experience in capital financing, debt refinancing, strategic repositioning, development and restructuring as well as private placement offerings in connection with the sale and acquisition of various entities. Michael specializes in reverse merger transactions.
Michael has assisted companies in the preparation and review of audits in accordance with auditing standards generally accepted in the USA, plus has prepared numerous market and financial feasibility studies that directly led to the raising of 1.5 billion dollars in financing. He has experience in capital financing, debt refinancing, strategic repositioning, development and restructuring as well as private placement offerings in connection with the sale and acquisition of various entities.
Mr. Pollack is a member of the American Institute of Certified Public Accountants, as well as the Pennsylvania Institute of Certified Public Accountants and is licensed as a CPA in the State of New York and New Jersey. Additional information on the CPA firm can be obtained on the internet at: http://www.bagelljosephs.com/ .
Additionally, Keith Houser, CEO of BTMD announced that the Company has hired William Haseltine, Attorney at Law, Arlington, Virginia to represent the Company. Mr. Houser said, "I have known Mr. Haseltine for a year and upon completing due diligence found him well qualified in SEC matters. His expertise in SEC regulations, international securities regulations and private placement of funds make him well suited for the business purposes of the Company and our goals."
Mr. Haseltine has privately practiced law in international business securities and compliance as well as international capital markets since 1995. From 1986-1995, Mr. Haseltine served at the U.S. Securities & Exchange Commission, Washington, D.C., where he was a Special Counsel in the Division of Corporation Finance, and worked for the Office of the Assistance Director, Office of the Chief Counsel and Office of International Corporate Finance.
Mr. Haseltine received his LLM in Securities at Georgetown University Law Center, in 1984; J.D. (cum laude) at Whittier College of Law, 1983, and completed MBA International Business and Finance studies at the George Washington University, School of Government & Business Administration, 1984- 1986. He holds a B. A. from Texas Tech University, Lubbock, Texas, 1979. He is a member of the California and Washington, DC bars. For more information you can look up on the Internet: http://www.wbhlaw.net/ .
Safe Harbor for Forward-Looking Statements.
This press contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). In Particular, when used in the preceding discussion, the words "plan," "confident that," "believe," "scheduled," "expect," or "intend to," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, the ability of the company to complete the planned bridge financing, market conditions, the general acceptance of the Company's products and technologies, competitive actors, timing, and other risks described in the Company's SEC reports and Filings.
BioTech Medics, Inc.CONTACT: Keith Houser, +1-972-274-5533 for BioTech Medics, Inc.